Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Aug
10
2016
ITC’S Bow To PTAB’S Invalidity Ruling Adds New Dimension To Section 337 Investigations Squire Patton Boggs (US) LLP
Jul
17
2020
The ITC Expands its Approach to Issuing Cease and Desist Orders Squire Patton Boggs (US) LLP
Nov
28
2016
Patents – A Novel and Inventive Approach to Brexit? Squire Patton Boggs (US) LLP
Dec
16
2016
Recent Ruling Is A Game Changer In IPEC Squire Patton Boggs (US) LLP
Nov
3
2020
Messi Scores Goal in Trade Mark Dispute: Registering Celebrity Names as Trade Marks Squire Patton Boggs (US) LLP
Jan
9
2017
Data Privacy – Commission Changes Existing Decisions on Standard Contractual Clauses and Adequacy of Third Countries Squire Patton Boggs (US) LLP
Feb
16
2017
Football Club Badges: Legal Implications of Misuse Squire Patton Boggs (US) LLP
Mar
9
2017
Patent Trial and Appeal Board Reverses Subject Matter Eligibility Rejections Based on Incomplete Analysis Squire Patton Boggs (US) LLP
Mar
30
2021
Influencer Held in Breach of ASA Code in £8,000 Prize Giveaway Squire Patton Boggs (US) LLP
Apr
6
2021
Discretionary Denial of Institution of an IPR Disfavored Where Litigation Already Stayed or Petitioner Stipulates to Estoppel Squire Patton Boggs (US) LLP
May
6
2021
When Compulsory Licenses Apparently Just Won’t Do: The US Backs Waiver of Rights to IP Relating to COVID-19 Squire Patton Boggs (US) LLP
May
13
2021
ITC Initiates Pilot Program to Allow ALJs to Issue Interim Initial Determinations Squire Patton Boggs (US) LLP
Jun
20
2017
A New Slant: Supreme Court Invalidates Bar to Registering “Disparaging” Trademarks Squire Patton Boggs (US) LLP
Jun
15
2021
CFIUS Filing: Zhejiang Youchuang Venture Capital Investment, Shaoxing City Keqiao District Paradise Silicon Intelligent Robot Industrial Investment Partnership, and EKSO Bionics Holdings Squire Patton Boggs (US) LLP
Feb
10
2022
Yes, A Secret Process Can (Still) Create an On-Sale Bar Squire Patton Boggs (US) LLP
Feb
24
2022
Yes, You Can Bargain Away Your Right to File IPR Petitions Squire Patton Boggs (US) LLP
Mar
23
2022
FBI Warns U.S. Critical Infrastructure Subject to Reconnaissance for Cyberattacks Squire Patton Boggs (US) LLP
Nov
1
2017
‘Minute Winner’ loses out in TV format copyright claim Squire Patton Boggs (US) LLP
Jan
24
2018
Here’s a Nug of Information: California Is Now Accepting Cannabis-Related Trademarks Squire Patton Boggs (US) LLP
Aug
19
2015
Single Party Rule for Direct Patent Infringement: Guidance from Federal Circuit’s latest Akamai vs. Limelight decision Squire Patton Boggs (US) LLP
Jun
11
2018
Patent Venue Mandamus Has Its Limits Squire Patton Boggs (US) LLP
May
5
2023
The Subvertising Movement: Protecting your Brand from “Brandalism” Squire Patton Boggs (US) LLP
Oct
20
2015
The Federal Circuit Declines To Revisit Its Decision That The Biosimilars Patent Dance Is Optional – Next Stop, Supreme Court? Squire Patton Boggs (US) LLP
Dec
3
2018
Are Trademark Licensees Protected In A Licensor Bankruptcy? Squire Patton Boggs (US) LLP
Mar
3
2019
The EU’s New Copyright Directive – an update Squire Patton Boggs (US) LLP
Apr
9
2019
Using the ® and ™ symbols on your trade marks Squire Patton Boggs (US) LLP
Nov
15
2023
Proactive Strategies in IPRs after Allgenesis Squire Patton Boggs (US) LLP
Nov
29
2023
Performance Improvement Technology In Elite Sports Squire Patton Boggs (US) LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins